- Home
- EBF vs KROS Comparison
EBF vs KROS Comparison
Compare EBF & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBF
- KROS
- Stock Information
- Founded
- EBF 1909
- KROS 2015
- Country
- EBF United States
- KROS United States
- Employees
- EBF N/A
- KROS N/A
- Industry
- EBF Office Equipment/Supplies/Services
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- EBF Consumer Discretionary
- KROS Health Care
- Exchange
- EBF Nasdaq
- KROS Nasdaq
- Market Cap
- EBF 551.3M
- KROS 465.2M
- IPO Year
- EBF N/A
- KROS 2020
- Fundamental
- Price
- EBF $19.86
- KROS $10.30
- Analyst Decision
- EBF
- KROS Buy
- Analyst Count
- EBF 0
- KROS 12
- Target Price
- EBF N/A
- KROS $27.86
- AVG Volume (30 Days)
- EBF 272.2K
- KROS 758.7K
- Earning Date
- EBF 04-21-2025
- KROS 05-07-2025
- Dividend Yield
- EBF 5.04%
- KROS N/A
- EPS Growth
- EBF N/A
- KROS N/A
- EPS
- EBF 1.58
- KROS N/A
- Revenue
- EBF $399,351,000.00
- KROS $3,550,000.00
- Revenue This Year
- EBF N/A
- KROS $65.83
- Revenue Next Year
- EBF N/A
- KROS $1.36
- P/E Ratio
- EBF $12.80
- KROS N/A
- Revenue Growth
- EBF N/A
- KROS 2250.99
- 52 Week Low
- EBF $18.88
- KROS $9.41
- 52 Week High
- EBF $25.75
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- EBF 39.43
- KROS 39.09
- Support Level
- EBF $19.35
- KROS $11.18
- Resistance Level
- EBF $20.55
- KROS $11.63
- Average True Range (ATR)
- EBF 0.47
- KROS 0.47
- MACD
- EBF -0.06
- KROS -0.07
- Stochastic Oscillator
- EBF 23.83
- KROS 38.20
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialities, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360º Custom LabelsSM, ColorWorx, Enfusion, among others.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.